Featured Clinical Focus
AML
Biomarker-Driven Lung Cancer
Breast Cancer
CAR T-Cell Therapy
Chronic Lymphocytic Leukemia
EGFR+ Lung Cancer
Follicular Lymphoma
GI Cancers
HCC
HER2-Positive Breast Cancer
Lung Cancer
Lymphomas
Mantle Cell Lymphoma
MPNs
Multiple Myeloma
Prostate Cancer
Renal Cell Carcinoma
Thyroid Cancers
Clinical Focus
Brain Cancer
Breast Cancer
Gastrointestinal Cancer
Genitourinary Cancers
Gynecologic Cancers
Head & Neck Cancers
Hematology
Leukemias
Lung Cancer
Lymphomas
Melanoma
Sarcoma
Skin Cancers
Thyroid Cancers
News
All News
Press Releases
Conferences
Conference Coverage
Conference Listing
Media
All Videos
Case-Based Peer Perspectives
Expert Perspective Virtual Tumor Board
Interviews
Investigator Perspectives
Medical World News
Podcasts
Precision Medicine
Publications
All Publications
CBPP Spotlight Live
Evolving Paradigms
Targeted Therapies in Oncology
Resources
Education
Partners
Subscribe
eNewsletter
Search
Featured Clinical Focus
AML
Biomarker-Driven Lung Cancer
Breast Cancer
CAR T-Cell Therapy
Chronic Lymphocytic Leukemia
EGFR+ Lung Cancer
Follicular Lymphoma
GI Cancers
HCC
HER2-Positive Breast Cancer
Lung Cancer
Lymphomas
Mantle Cell Lymphoma
MPNs
Multiple Myeloma
Prostate Cancer
Renal Cell Carcinoma
Thyroid Cancers
Clinical Focus
See All >
Brain Cancer
Breast Cancer
Gastrointestinal Cancer
Genitourinary Cancers
Gynecologic Cancers
Head & Neck Cancers
Hematology
Leukemias
Lung Cancer
Lymphomas
Melanoma
Sarcoma
Skin Cancers
Thyroid Cancers
Conference Preview: SABCS 2020 | Investigator Perspectives
The most interesting developments and approvals in breast cancer treatment in the last year and expectations regarding data that will be presented on at the upcoming 2020 San Antonio Breast Cancer Symposium.
home
EP 1: Breast Cancer Treatment: Year in Review
EP 2: SABCS 2020: CDK4/6 Inhibitors for Breast Cancer
EP 3: SABCS 2020: Other Oral Therapies for Breast Cancer
EP 4: SABCS 2020: AKT Inhibitors for TNBC
EP 5: Precision Medicine in Breast Cancer